International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials.
Qual Life Res
; 32(8): 2155-2163, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37217665
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Neoplasms
Type of study:
Guideline
/
Health_technology_assessment
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Qual Life Res
Journal subject:
REABILITACAO
/
TERAPEUTICA
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands